News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Toby Eyre Shared NEJM Article on Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia
Toby Eyre/X
Jun 17, 2025, 09:52

Toby Eyre Shared NEJM Article on Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia

Toby Eyre, CLL specialist at the Oxford University Hospitals, shared a post on X:

“Big CLL news!
Munir et al
OS and PFS adv for MRD driven I and V over ibrutinib in 1L CLL EHA 2025.
Congrats to all FLAIR trial group.
Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia, New England Journal of Medicine”

Title: Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia

Journal: NEJM

Authors: Talha Munir, Sean Girvan, David A. Cairns, Adrian Bloor, David Allsup, Abraham M. Varghese, Satyen Gohil, Shankara Paneesha, Andrew Pettitt, Toby Eyre, Christopher P. Fox, Francesco Forconi, Constantine Balotis, Nicholas Pemberton, Oonagh Sheehy, John Gribben, Nagah Elmusharaf, Simona Gatto, Gavin Preston, Anna Schuh, Renata Walewska, Lelia Duley, Nichola Webster, Surita Dalal, Andrew Rawstron, Dena Howard, Anna Hockaday, Sharon Jackson, Natasha Greatorex, Sue Bell, David Stones, Julia M. Brown, Piers E.M. Patten, Peter Hillmen

Read the full article.

Residual Disease-Guided Therapy

Read “25 Posts Not to Miss from EHA 2025“.

Residual Disease-Guided Therapy

Abraham M. Varghese Adrian Bloor Andrew Pettitt Andrew Rawstron Anna Hockaday Anna Schuh cancer Christopher P. Fox chronic lymphocytic leukemia CLL Constantine Balotis David A. Cairns David Allsup David Stones Dena Howard FLAIR FLAIR trial Francesco Forconi Gavin Preston ibrutinib John Gribben Julia M. Brown Lelia Duley Nagah Elmusharaf Natasha Greatorex NEJM Nichola Webster Nicholas Pemberton OncoDaily Oncology Oonagh Sheehy Oxford University Hospitals Peter Hillmen Piers E.M. Patten Renata Walewska Satyen Gohil Sean Girvan Shankara Paneesha Sharon Jackson Simona Gatto Sue Bell Surita Dalal Talha Munir Toby Eyre
Special Coverage
Blog
Jul 27, 2025, 18:45
Thanks for Showing Up, Sharing Your Work, and Believing in Collaboration at KCRS25 - KidneyCAN
Blog
Jul 27, 2025, 18:34
Hamza Hashmi: Sharing Ideas, Research, and Debates on Myeloma at the MM Sparks Event in Merida
Blog
Jul 27, 2025, 18:26
Cathy Eng: Always a Pleasure to Listen to Kristen Ciombor Give a Lecture about Immunotherapy in MSI-S CRC
Blog
Jul 27, 2025, 17:40
Aladina Foundation's Psychooncologists Offer a Consultation Outside the Hospital for Free
Opinion
Jul 27, 2025, 17:27
Ian Davis: Why Chemotherapy Has Not Stopped Working in Metastatic Prostate Cancer for More than 20 Years
Blog
Jul 27, 2025, 16:53
Luis E. Raez: The FLASCO “Breaking Barriers” Conference Returns This November
Career
Jul 27, 2025, 16:20
Justin Perry Has Been Promoted to Associate Member at Memorial Sloan Kettering Cancer Center
Blog
Jul 27, 2025, 16:04
Helena Linardou: ESMO Virtual Journal Club – July 2025 Edition
Blog
Jul 27, 2025, 15:57
A Deep Dive Into the Most Important Lung Cancer Trials Presented at ASCO25 - IASLC
Blog
Jul 27, 2025, 15:38
Sergio Cifuentes Canaval: First Meeting of Young Oncologists Group
Science
Jul 27, 2025, 15:14
Talha Badar: PII Trial of CPX-351 and Venetoclax
Insight
Jul 27, 2025, 15:13
Potential Breakthrough for Glioma: Servier’s Therapy Nears EMA Approval - Servier Pharmaceuticals